The upcoming event by the ISPE NJ Chapter will dive in to cell and gene therapy manufacturing with a stellar panel of industry leaders to discuss critical topics including:
The event will be hosted by Johnson and Johnson with dinner and cocktails. Do not miss out on the chapter’s premier event.
Robert Lechich, Principal Consultant, Global OT-IT Quality Services
Dominique DeJaeger, VP Johnson and Johnson
Innovative Medicines - Autologous Therapies Platform
Rich Bland, Senior Director of Supply Chain, Cellares
Emily Moran, Senior Vice President of Cell and Gene Manufacturing Center for Breakthrough Medicine
Ronit Slotky, PhD, Director Cell Therapies Manufacturing, Hackensack University Medical Center
Thomas Heathman, PhD, Chief Commercial Officer, Ori Biotech
David Smith, PhD, VP of Development, BioCentriq